Overuse of paracetamol caffeine aspirin powders affects cerebral glucose metabolism in chronic migraine patients

European Journal of Neurology

Volumn 20, Issue 4, 2013, Pages 655-662

  Di, W ^a   Shi, X ^a   Zhu, Y ^b   Tao, Y ^a   Qi, W ^a   Luo, N ^a   Xiao, Z ^a   Yi, C ^a   Miao, J ^a   Zhang, A ^a   Zhang, X ^a   Fang, Y ^a  

^a SUN YAT SEN UNIVERSITY   (China)

^b SUN YAT SEN UNIVERSITY   (China)

Author keywords

Analgesic; Chronic migraine; Glucose metabolism; Insula; Medication overuse; PET CT

Indexed keywords

ERGOTAMINE; EXCEDRIN; FLUORODEOXYGLUCOSE F 18; GLUCOSE; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; BRAIN METABOLISM; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG ABUSE; FEMALE; FUNCTION TEST; FUNCTIONAL NEUROIMAGING; GLUCOSE METABOLISM; HUMAN; INSULA; MALE; MIDDLE TEMPORAL GYRUS; MINI MENTAL STATE EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; POWDER; PRIORITY JOURNAL; SUPERIOR TEMPORAL GYRUS; TRANSFORMED MIGRAINE; VISUAL ANALOG SCALE;

ACETAMINOPHEN; ADULT; ANALGESICS, NON-NARCOTIC; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; BRAIN; BRAIN CHEMISTRY; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CHRONIC DISEASE; FEMALE; FLUORODEOXYGLUCOSE F18; GLUCOSE; HEADACHE DISORDERS, SECONDARY; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROPSYCHOLOGICAL TESTS; PAIN MEASUREMENT; POSITRON-EMISSION TOMOGRAPHY; POWDERS; RADIOPHARMACEUTICALS;

EID: 84875044358     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/ene.12018     Document Type: Article

References (35)

1. Natoli JL, Manack A, Dean B, et al. Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010; 30: 599-609.
2. Lanteri-Minet M, Duru G, Mudge M, Cottrell S. Quality of life impairment, disability and economic burden associated with chronic daily headache, focusing on chronic migraine with or without medication overuse: a systematic review. Cephalalgia 2011; 31: 837-850.
3. Pascual J. Combination therapy for chronic migraine: bad news but not the last word. Neurology 2012; 78: 940-941.
4. Katsarava Z, Schneeweiss S, Kurth T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine. Neurology 2004; 62: 788-790.
5. Bigal ME, Lipton RB. Overuse of acute migraine medications and migraine chronification. Curr Pain Headache Rep 2009; 13: 301-307.
6. Bigal ME, Lipton RB. What predicts the change from episodic to chronic migraine? Curr Opin Neurol 2009; 22: 269-276.
7. Scher AI, Midgette LA, Lipton RB. Risk factors for headache chronification. Headache 2008; 48: 16-25.
8. Goadsby PJ. Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol 2006; 2: 401.
9. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008; 48: 1157-1168.
10. Bigal ME, Lipton RB. Excessive acute migraine medication use and migraine progression. Neurology 2008; 71: 1821-1828.
11. Luo N, Di W, Zhang A, et al. A randomized, one-year clinical trial comparing the efficacy of topiramate, flunarizine, and a combination of flunarizine and topiramate in migraine prophylaxis. Pain Med 2012; 13: 80-86.
12. Tepper SJ, Tepper DE. Breaking the cycle of medication overuse headache. Cleve Clin J Med 2010; 77: 236-242.
13. Fumal A, Laureys S, Di Clemente L, et al. Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006; 129: 543-550.
14. Sanchez DRM, Alvarez LJ. Functional neuroimaging of headaches. Lancet Neurol 2004; 3: 645-651.
15. Borsook D, Burstein R, Moulton E, Becerra L. Functional imaging of the trigeminal system: applications to migraine pathophysiology. Headache 2006; 46(Suppl 1): S32-S38.
16. Magis D, Bendtsen L, Goadsby PJ, et al. Evaluation and proposal for optimization of neurophysiological tests in migraine: part 2-neuroimaging and the nitroglycerin test. Cephalalgia 2007; 27: 1339-1359.
17. Aurora SK, Barrodale PM, Tipton RL, Khodavirdi A. Brainstem dysfunction in chronic migraine as evidenced by neurophysiological and positron emission tomography studies. Headache 2007; 47: 996-1007.
18. Kim JH, Kim S, Suh SI, Koh SB, Park KW, Oh K. Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study. Cephalalgia 2010; 30: 53-61.
19. Olesen J, Bousser MG, Diener HC, et al. New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006; 26: 742-746.
20. Silberstein SD, Lipton RB. Chronic daily headache. Curr Opin Neurol 2000; 13: 277-283.
21. Bahra A, Matharu MS, Buchel C, Frackowiak RS, Goadsby PJ. Brainstem activation specific to migraine headache. Lancet 2001; 357: 1016-1017.
22. Afridi SK, Matharu MS, Lee L, et al. A PET study exploring the laterality of brainstem activation in migraine using glyceryl trinitrate. Brain 2005; 128: 932-939.
23. Dasilva AF, Mendonca ME, Zaghi S, et al. tDCS-induced analgesia and electrical fields in pain-related neural networks in chronic migraine. Headache 2012; 52: 1283-1295.
24. Wang Z, Faith M, Patterson F, et al. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. J Neurosci 2007; 27: 14035-14040.
25. Myrick H, Anton RF, Li X, et al. Differential brain activity in alcoholics and social drinkers to alcohol cues: relationship to craving. Neuropsychopharmacology 2004; 29: 393-402.
26. Wexler BE, Gottschalk CH, Fulbright RK, et al. Functional magnetic resonance imaging of cocaine craving. Am J Psychiatry 2001; 158: 86-95.
27. Paulus MP. Decision-making dysfunctions in psychiatry-altered homeostatic processing?. Science 2007; 318: 602-606.
28. Ferraro S, Grazzi L, Mandelli ML, et al. Pain processing in medication overuse headache: a functional magnetic resonance imaging (fMRI) study. Pain Med 2011; 13: 255-262.
29. Usui C, Hatta K, Doi N, et al. Brain perfusion in fibromyalgia patients and its differences between responders and poor responders to gabapentin. Arthritis Res Ther 2010; 12: R64.
30. Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci USA 2003; 100: 253-258.
31. Raichle ME, Snyder AZ. A default mode of brain function: a brief history of an evolving idea. Neuroimage 2007; 37: 1083-1090, 1097-1099.
32. Jastorff J, Clavagnier S, Gergely G, Orban GA. Neural mechanisms of understanding rational actions: middle temporal gyrus activation by contextual violation. Cereb Cortex 2011; 21: 318-329.
33. Baars MA, van Boxtel MP, Jolles J. Migraine does not affect cognitive decline: results from the Maastricht aging study. Headache 2010; 50: 176-184.
34. Romigi A, Cervellino A, Marciani MG, et al. Cognitive and psychiatric effects of topiramate monotherapy in migraine treatment: an open study. Eur J Neurol 2008; 15: 190-195.
35. Paemeleire K. Brain lesions and cerebral functional impairment in migraine patients. J Neurol Sci 2009; 283: 134-136.